Pfizer (PFE) Proxy Filing summary

Executive summary

• Annual meeting scheduled for April 23, 2026, will be held virtually at 9:00 a.m. EDT.

• Shareholders can access proxy materials and vote online or request printed copies.

• Board recommends voting for four key proposals and against one shareholder proposal.

Voting matters and shareholder proposals

• Election of 12 directors is up for shareholder approval.

• Ratification of KPMG LLP as independent registered public accounting firm for 2026.

• Approval of the amended 2019 Stock Plan is proposed.

• Advisory approval of executive compensation for 2026 is on the agenda.

• Shareholder proposal to adopt an Independent Chair Policy is recommended against by the Board.

Board of directors and corporate governance

• Board recommends the election of Ronald E. Blaylock, Albert Bourla, Mortimer J. Buckley, Susan Desmond-Hellmann, Joseph J. Echevarria, Scott Gottlieb, Dan R. Littman, Shantanu Narayen, Suzanne Nora Johnson, James Quincey, James C. Smith, and Cyrus Taraporevala.